Antisense oligomers for treatment of conditions and diseases Grant US-11873490-B2 United States of America 16 Jan 2024
OPA1 antisense oligomers for treatment of conditions and diseases Grant US-11814622-B2 United States of America 14 Nov 2023
Modulation of gene expression and screening for deregulated protein expression Grant US-11702660-B2 United States of America 18 Jul 2023
Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet… Grant US-11083745-B2 United States of America 10 Aug 2021
Modulation of gene expression and screening for deregulated protein expression Grant US-10941405-B2 United States of America 09 Mar 2021
Antisense oligomers for treatment of conditions and diseases Grant US-10913947-B2 United States of America 09 Feb 2021
Targeted augmentation of nuclear gene output Grant US-10696969-B2 United States of America 30 Jun 2020
Antisense oligomers for treatment of conditions and diseases Grant US-10683503-B2 United States of America 16 Jun 2020
Modulation of gene expression and screening for deregulated protein expression Grant US-10196639-B2 United States of America 05 Feb 2019
Targeted augmentation of nuclear gene output Grant US-9976143-B2 United States of America 22 May 2018